Omnicell

JANUARY 10, 2023

Stephanie Gallagher, PharmD, MBA Senior Clinical Product Marketing Manager, Omnicell The sterile compounding industry has been under great scrutiny due to alarming frequency and severity of adverse events from IV compounding, such as the New England Compounding Center catastrophe in 2012.

Compounding 52

Compounding Sterile Compounds Omnicell Patient Care 52

Omnicell

JANUARY 10, 2023

Studies have shown that one out of every ten can put patients at risk. Sterile compounding is also one of the costliest functions in pharmacy operations. Still, many hospital pharmacies continue to struggle to improve safety and efficiency in their sterile compounding operations. 5 at 2 p.m. 5 at 2 p.m. 5 at 2 p.m.

Sterile Compounds 52

Sterile Compounds Omnicell Compounding Hospitals 52

Omnicell

MARCH 27, 2023

BMHCC is simultaneously focused on the challenges of reducing acute care drug spend and improving their drug delivery model, with IV preparation and diversion detection as the chief drug delivery concerns. The goal is to move pharmacists and other clinicians to the center of patient care where they can practice at the top of their license.

Sterile Compounds 52

Sterile Compounds Medication Dispensing Omnicell Hospitals 52

Omnicell

FEBRUARY 14, 2023

BMHCC is simultaneously focused on the challenges of reducing acute care drug spend and improving their drug delivery model, with IV preparation and diversion detection as the chief drug delivery concerns. The goal is to move pharmacists and other clinicians to the center of patient care where they can practice at the top of their license.

Sterile Compounds 52

Sterile Compounds Medication Dispensing Omnicell Hospitals 52